{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:23:44Z","timestamp":1757618624848,"version":"3.44.0"},"reference-count":183,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s40256-025-00741-0","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T03:24:21Z","timestamp":1750994661000},"page":"601-632","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Stem Cell Therapy in Ischemic Heart Failure"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3717-2678","authenticated-orcid":false,"given":"Quanchi","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"key":"741_CR1","unstructured":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2133-61."},{"issue":"25","key":"741_CR2","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1161\/CIRCULATIONAHA.123.067097","volume":"149","author":"T Liu","year":"2024","unstructured":"Liu T, Hao Y, Zhang Z, Zhou H, Peng S, Zhang D, et al. Advanced cardiac patches for the treatment of myocardial infarction. Circulation. 2024;149(25):2002\u201320.","journal-title":"Circulation"},{"issue":"10","key":"741_CR3","doi-asserted-by":"publisher","first-page":"276","DOI":"10.31083\/j.rcm2410276","volume":"24","author":"L Miao","year":"2023","unstructured":"Miao L, Liu YL. Research advances in targeted therapy for heart failure. Rev Cardiovasc Med. 2023;24(10):276.","journal-title":"Rev Cardiovasc Med"},{"key":"741_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/ijms25073778","volume":"25","author":"IT Tsai","year":"2024","unstructured":"Tsai IT, Sun CK. Stem cell therapy against ischemic heart disease. Int J Mol Sci. 2024;25:7.","journal-title":"Int J Mol Sci"},{"key":"741_CR5","doi-asserted-by":"publisher","first-page":"1408679","DOI":"10.3389\/fphar.2024.1408679","volume":"15","author":"C von Bibra","year":"2024","unstructured":"von Bibra C, Hinkel R. Non-human primate studies for cardiomyocyte transplantation-ready for translation? Front Pharmacol. 2024;15:1408679.","journal-title":"Front Pharmacol"},{"issue":"4","key":"741_CR6","first-page":"65","volume":"12","author":"RG Carbone","year":"2023","unstructured":"Carbone RG, Negrini S, Murdaca G, Fontana V, Puppo F. Stem cells treatment in chronic ischemic heart disease: a narrative review. Am J Stem Cells. 2023;12(4):65\u201372.","journal-title":"Am J Stem Cells."},{"issue":"4","key":"741_CR7","doi-asserted-by":"publisher","first-page":"260","DOI":"10.4252\/wjsc.v13.i4.260","volume":"13","author":"N Ahamad","year":"2021","unstructured":"Ahamad N, Singh BB. Calcium channels and their role in regenerative medicine. World J Stem Cells. 2021;13(4):260\u201380.","journal-title":"World J Stem Cells."},{"key":"741_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms17010141","volume":"17","author":"S Menon","year":"2016","unstructured":"Menon S, Shailendra S, Renda A, Longaker M, Quarto N. An overview of direct somatic reprogramming: the ins and outs of iPSCs. Int J Mol Sci. 2016;17:1.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"741_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1089\/teb.2007.0216","volume":"14","author":"DM Choumerianou","year":"2008","unstructured":"Choumerianou DM, Dimitriou H, Kalmanti M. Stem cells: promises versus limitations. Tissue Eng Part B Rev. 2008;14(1):53\u201360.","journal-title":"Tissue Eng Part B Rev"},{"issue":"1","key":"741_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000345615","volume":"85","author":"G Kolios","year":"2013","unstructured":"Kolios G, Moodley Y. Introduction to stem cells and regenerative medicine. Respiration. 2013;85(1):3\u201310.","journal-title":"Respiration"},{"issue":"4","key":"741_CR11","first-page":"219","volume":"11","author":"N Khanlarkhani","year":"2016","unstructured":"Khanlarkhani N, Baazm M, Mohammadzadeh F, Najafi A, Mehdinejadiani S, Sobhani A. Multipotent stem cell and reproduction. J Stem Cells. 2016;11(4):219\u201329.","journal-title":"J Stem Cells"},{"issue":"3","key":"741_CR12","doi-asserted-by":"publisher","first-page":"329","DOI":"10.18388\/abp.2015_1023","volume":"62","author":"J Dulak","year":"2015","unstructured":"Dulak J, Szade K, Szade A, Nowak W, J\u00f3zkowicz A. Adult stem cells: hopes and hypes of regenerative medicine. Acta Biochim Pol. 2015;62(3):329\u201337.","journal-title":"Acta Biochim Pol"},{"issue":"1","key":"741_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12951-023-01778-6","volume":"21","author":"J Zou","year":"2023","unstructured":"Zou J, Yang W, Cui W, Li C, Ma C, Ji X, et al. Therapeutic potential and mechanisms of mesenchymal stem cell-derived exosomes as bioactive materials in tendon-bone healing. J Nanobiotechnol. 2023;21(1):14.","journal-title":"J Nanobiotechnol"},{"issue":"7689","key":"741_CR14","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nature25022","volume":"553","author":"E Laurenti","year":"2018","unstructured":"Laurenti E, G\u00f6ttgens B. From haematopoietic stem cells to complex differentiation landscapes. Nature. 2018;553(7689):418\u201326.","journal-title":"Nature"},{"issue":"17","key":"741_CR15","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1182\/blood-2014-12-570200","volume":"125","author":"CJ Eaves","year":"2015","unstructured":"Eaves CJ. Hematopoietic stem cells: concepts, definitions, and the new reality. Blood. 2015;125(17):2605\u201313.","journal-title":"Blood"},{"key":"741_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/ijms17071009","volume":"17","author":"L Pleyer","year":"2016","unstructured":"Pleyer L, Valent P, Greil R. Mesenchymal stem and progenitor cells in normal and dysplastic hematopoiesis-masters of survival and clonality? Int J Mol Sci. 2016;17:7.","journal-title":"Int J Mol Sci"},{"key":"741_CR17","doi-asserted-by":"crossref","unstructured":"Augustine R, Gezek M, Nikolopoulos VK, Buck PL, Bostanci NS, Camci-Unal G. Stem cells in bone tissue engineering: progress, promises and challenges. Stem Cell Rev Rep. 2024.","DOI":"10.1007\/s12015-024-10738-y"},{"key":"741_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102235","volume":"99","author":"S Huo","year":"2024","unstructured":"Huo S, Tang X, Chen W, Gan D, Guo H, Yao Q, et al. Epigenetic regulations of cellular senescence in osteoporosis. Ageing Res Rev. 2024;99: 102235.","journal-title":"Ageing Res Rev"},{"issue":"4","key":"741_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13586","volume":"57","author":"X Li","year":"2024","unstructured":"Li X, Zhang D, Yu Y, Wang L, Zhao M. Umbilical cord-derived mesenchymal stem cell secretome promotes skin regeneration and rejuvenation: from mechanism to therapeutics. Cell Prolif. 2024;57(4): e13586.","journal-title":"Cell Prolif"},{"issue":"7","key":"741_CR20","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1007\/s10815-023-02856-2","volume":"40","author":"J Giri","year":"2023","unstructured":"Giri J, Modi D. Endometrial and placental stem cells in successful and pathological pregnancies. J Assist Reprod Genet. 2023;40(7):1509\u201322.","journal-title":"J Assist Reprod Genet"},{"issue":"1","key":"741_CR21","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s13287-022-02985-y","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu J, Gao J, Liang Z, Gao C, Niu Q, Wu F, et al. Mesenchymal stem cells and their microenvironment. Stem Cell Res Ther. 2022;13(1):429.","journal-title":"Stem Cell Res Ther"},{"key":"741_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176719","volume":"977","author":"J Pharoun","year":"2024","unstructured":"Pharoun J, Berro J, Sobh J, Abou-Younes MM, Nasr L, Majed A, et al. Mesenchymal stem cells biological and biotechnological advances: Implications for clinical applications. Eur J Pharmacol. 2024;977: 176719.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"741_CR23","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s13287-024-03856-4","volume":"15","author":"Y Qu","year":"2024","unstructured":"Qu Y, Wang Z, Dong L, Zhang D, Shang F, Li A, et al. Natural small molecules synergize mesenchymal stem cells for injury repair in vital organs: a comprehensive review. Stem Cell Res Ther. 2024;15(1):243.","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"741_CR24","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.stem.2020.09.014","volume":"27","author":"S Yamanaka","year":"2020","unstructured":"Yamanaka S. Pluripotent stem cell-based cell therapy-promise and challenges. Cell Stem Cell. 2020;27(4):523\u201331.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"741_CR25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13287-024-03727-y","volume":"15","author":"HS Wang","year":"2024","unstructured":"Wang HS, Ma XR, Guo YH. Development and application of haploid embryonic stem cells. Stem Cell Res Ther. 2024;15(1):116.","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"741_CR26","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/biolre\/ioy256","volume":"100","author":"DE Goszczynski","year":"2019","unstructured":"Goszczynski DE, Cheng H, Demyda-Peyr\u00e1s S, Medrano JF, Wu J, Ross PJ. In vitro breeding: application of embryonic stem cells to animal production\u2020. Biol Reprod. 2019;100(4):885\u201395.","journal-title":"Biol Reprod"},{"issue":"4","key":"741_CR27","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663\u201376.","journal-title":"Cell"},{"issue":"15","key":"741_CR28","first-page":"2346","volume":"51","author":"S Yamanaka","year":"2006","unstructured":"Yamanaka S, Takahashi K. Induction of pluripotent stem cells from mouse fibroblast cultures. Tanpakushitsu Kakusan Koso. 2006;51(15):2346\u201351.","journal-title":"Tanpakushitsu Kakusan Koso"},{"issue":"1","key":"741_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1152\/physrev.00039.2017","volume":"99","author":"P Karagiannis","year":"2019","unstructured":"Karagiannis P, Takahashi K, Saito M, Yoshida Y, Okita K, Watanabe A, et al. Induced pluripotent stem cells and their use in human models of disease and development. Physiol Rev. 2019;99(1):79\u2013114.","journal-title":"Physiol Rev"},{"issue":"8","key":"741_CR30","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1080\/14737140.2021.1915137","volume":"21","author":"H Fatma","year":"2021","unstructured":"Fatma H, Siddique HR. Pluripotency inducing Yamanaka factors: role in stemness and chemoresistance of liver cancer. Expert Rev Anticancer Ther. 2021;21(8):853\u201364.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"5","key":"741_CR31","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.copbio.2007.09.007","volume":"18","author":"M Lewitzky","year":"2007","unstructured":"Lewitzky M, Yamanaka S. Reprogramming somatic cells towards pluripotency by defined factors. Curr Opin Biotechnol. 2007;18(5):467\u201373.","journal-title":"Curr Opin Biotechnol"},{"issue":"7909","key":"741_CR32","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41586-022-04593-5","volume":"605","author":"J Guan","year":"2022","unstructured":"Guan J, Wang G, Wang J, Zhang Z, Fu Y, Cheng L, et al. Chemical reprogramming of human somatic cells to pluripotent stem cells. Nature. 2022;605(7909):325\u201331.","journal-title":"Nature"},{"key":"741_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114817","volume":"163","author":"Y Pan","year":"2023","unstructured":"Pan Y, Wu W, Jiang X, Liu Y. Mesenchymal stem cell-derived exosomes in cardiovascular and cerebrovascular diseases: from mechanisms to therapy. Biomed Pharmacother. 2023;163: 114817.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"741_CR34","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1093\/cvr\/cvab135","volume":"118","author":"R Bolli","year":"2022","unstructured":"Bolli R, Solankhi M, Tang XL, Kahlon A. Cell therapy in patients with heart failure: a comprehensive review and emerging concepts. Cardiovasc Res. 2022;118(4):951\u201376.","journal-title":"Cardiovasc Res"},{"key":"741_CR35","doi-asserted-by":"publisher","first-page":"1344885","DOI":"10.3389\/fphys.2023.1344885","volume":"14","author":"MA Chowdhury","year":"2023","unstructured":"Chowdhury MA, Zhang JJ, Rizk R, Chen WCW. Stem cell therapy for heart failure in the clinics: new perspectives in the era of precision medicine and artificial intelligence. Front Physiol. 2023;14:1344885.","journal-title":"Front Physiol"},{"key":"741_CR36","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.yjmcc.2023.12.001","volume":"187","author":"Y Soma","year":"2024","unstructured":"Soma Y, Tani H, Morita-Umei Y, Kishino Y, Fukuda K, Tohyama S. Pluripotent stem cell-based cardiac regenerative therapy for heart failure. J Mol Cell Cardiol. 2024;187:90\u2013100.","journal-title":"J Mol Cell Cardiol"},{"key":"741_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/ijms25126634","volume":"25","author":"J Seth","year":"2024","unstructured":"Seth J, Sharma S, Leong CJ, Vaibhav V, Nelson P, Shokravi A, et al. The use of hematopoietic stem cells for heart failure: a systematic review. Int J Mol Sci. 2024;25:12.","journal-title":"Int J Mol Sci"},{"issue":"21","key":"741_CR38","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1016\/j.jacc.2021.09.019","volume":"78","author":"J Zhang","year":"2021","unstructured":"Zhang J, Bolli R, Garry DJ, Marb\u00e1n E, Menasch\u00e9 P, Zimmermann WH, et al. Basic and translational research in cardiac repair and regeneration: JACC state-of-the-art review. J Am Coll Cardiol. 2021;78(21):2092\u2013105.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"741_CR39","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.jacc.2011.06.016","volume":"58","author":"BE Strauer","year":"2011","unstructured":"Strauer BE, Steinhoff G. 10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice. J Am Coll Cardiol. 2011;58(11):1095\u2013104.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"741_CR40","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.3727\/096368911X627462","volume":"21","author":"J Otto Beitnes","year":"2012","unstructured":"Otto Beitnes J, Oie E, Shahdadfar A, Karlsen T, M\u00fcller RM, Aakhus S, et al. Intramyocardial injections of human mesenchymal stem cells following acute myocardial infarction modulate scar formation and improve left ventricular function. Cell Transplant. 2012;21(8):1697\u2013709.","journal-title":"Cell Transplant"},{"issue":"5","key":"741_CR41","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/stem.632","volume":"29","author":"A Acquistapace","year":"2011","unstructured":"Acquistapace A, Bru T, Lesault PF, Figeac F, Coudert AE, le Coz O, et al. Human mesenchymal stem cells reprogram adult cardiomyocytes toward a progenitor-like state through partial cell fusion and mitochondria transfer. Stem Cells. 2011;29(5):812\u201324.","journal-title":"Stem Cells"},{"issue":"11","key":"741_CR42","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1016\/j.ymthe.2018.08.012","volume":"26","author":"S Yoshida","year":"2018","unstructured":"Yoshida S, Miyagawa S, Fukushima S, Kawamura T, Kashiyama N, Ohashi F, et al. Maturation of human induced pluripotent stem cell-derived cardiomyocytes by soluble factors from human mesenchymal stem cells. Mol Ther. 2018;26(11):2681\u201395.","journal-title":"Mol Ther"},{"issue":"4","key":"741_CR43","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/BF03195227","volume":"48","author":"MZ Ratajczak","year":"2007","unstructured":"Ratajczak MZ, Zuba-Surma EK, Machalinski B, Kucia M. Bone-marrow-derived stem cells\u2013our key to longevity? J Appl Genet. 2007;48(4):307\u201319.","journal-title":"J Appl Genet"},{"issue":"9","key":"741_CR44","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/j.jacc.2006.02.003","volume":"47","author":"P Anversa","year":"2006","unstructured":"Anversa P, Leri A, Kajstura J. Cardiac regeneration. J Am Coll Cardiol. 2006;47(9):1769\u201376.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"741_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2024.102394","volume":"20","author":"X Sun","year":"2025","unstructured":"Sun X, Wu J, Mourad O, Li R, Nunes SS. Microvessel co-transplantation improves poor remuscularization by hiPSC-cardiomyocytes in a complex disease model of myocardial infarction and type 2 diabetes. Stem Cell Rep. 2025;20(2): 102394.","journal-title":"Stem Cell Rep."},{"issue":"10","key":"741_CR46","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.2174\/1574888X19666230913154544","volume":"19","author":"L Li","year":"2024","unstructured":"Li L, Hua S, You L, Zhong T. Secretome derived from mesenchymal stem\/stromal cells: a promising strategy for diabetes and its complications. Curr Stem Cell Res Ther. 2024;19(10):1328\u201350.","journal-title":"Curr Stem Cell Res Ther"},{"issue":"12","key":"741_CR47","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1161\/01.ATV.0000190701.92007.6d","volume":"25","author":"H Nakagami","year":"2005","unstructured":"Nakagami H, Maeda K, Morishita R, Iguchi S, Nishikawa T, Takami Y, et al. Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arterioscler Thromb Vasc Biol. 2005;25(12):2542\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"741_CR48","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.bbrc.2007.09.058","volume":"363","author":"S Sadat","year":"2007","unstructured":"Sadat S, Gehmert S, Song YH, Yen Y, Bai X, Gaiser S, et al. The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF. Biochem Biophys Res Commun. 2007;363(3):674\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"741_CR49","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","volume":"5","author":"RH Lee","year":"2009","unstructured":"Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL, et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell. 2009;5(1):54\u201363.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"741_CR50","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s12967-020-02504-8","volume":"18","author":"C Sid-Otmane","year":"2020","unstructured":"Sid-Otmane C, Perrault LP, Ly HQ. Mesenchymal stem cell mediates cardiac repair through autocrine, paracrine and endocrine axes. J Transl Med. 2020;18(1):336.","journal-title":"J Transl Med"},{"key":"741_CR51","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","volume":"30","author":"M Colombo","year":"2014","unstructured":"Colombo M, Raposo G, Th\u00e9ry C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 2014;30:255\u201389.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"1","key":"741_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-013-1084-8","volume":"113","author":"JC Akers","year":"2013","unstructured":"Akers JC, Gonda D, Kim R, Carter BS, Chen CC. Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J Neurooncol. 2013;113(1):1\u201311.","journal-title":"J Neurooncol"},{"issue":"3","key":"741_CR53","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2741\/209","volume":"3","author":"KM Haizlip","year":"2011","unstructured":"Haizlip KM, Janssen PM. In vitro studies of early cardiac remodeling: impact on contraction and calcium handling. Front Biosci (Schol Ed). 2011;3(3):1047\u201357.","journal-title":"Front Biosci (Schol Ed)"},{"issue":"1","key":"741_CR54","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10557-021-07228-5","volume":"37","author":"K Wang","year":"2023","unstructured":"Wang K, Gao XQ, Wang T, Zhou LY. The function and therapeutic potential of circular RNA in cardiovascular diseases. Cardiovasc Drugs Ther. 2023;37(1):181\u201398.","journal-title":"Cardiovasc Drugs Ther"},{"key":"741_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.616161","volume":"8","author":"D Zheng","year":"2020","unstructured":"Zheng D, Huo M, Li B, Wang W, Piao H, Wang Y, et al. The role of exosomes and exosomal microRNA in cardiovascular disease. Front Cell Dev Biol. 2020;8: 616161.","journal-title":"Front Cell Dev Biol."},{"issue":"1","key":"741_CR56","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s13287-020-01737-0","volume":"11","author":"H Cheng","year":"2020","unstructured":"Cheng H, Chang S, Xu R, Chen L, Song X, Wu J, et al. Hypoxia-challenged MSC-derived exosomes deliver miR-210 to attenuate post-infarction cardiac apoptosis. Stem Cell Res Ther. 2020;11(1):224.","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"741_CR57","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41419-020-2545-6","volume":"11","author":"Y Peng","year":"2020","unstructured":"Peng Y, Zhao JL, Peng ZY, Xu WF, Yu GL. Exosomal miR-25-3p from mesenchymal stem cells alleviates myocardial infarction by targeting pro-apoptotic proteins and EZH2. Cell Death Dis. 2020;11(5):317.","journal-title":"Cell Death Dis"},{"issue":"9","key":"741_CR58","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1002\/stem.2078","volume":"33","author":"S Bobis-Wozowicz","year":"2015","unstructured":"Bobis-Wozowicz S, Kmiotek K, Sekula M, Kedracka-Krok S, Kamycka E, Adamiak M, et al. Human induced pluripotent stem cell-derived microvesicles transmit RNAs and proteins to recipient mature heart cells modulating cell fate and behavior. Stem Cells. 2015;33(9):2748\u201361.","journal-title":"Stem Cells"},{"key":"741_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.647415","volume":"9","author":"SE Spellicy","year":"2021","unstructured":"Spellicy SE, Hess DC. The immunomodulatory capacity of induced pluripotent stem cells in the post-stroke environment. Front Cell Dev Biol. 2021;9: 647415.","journal-title":"Front Cell Dev Biol."},{"issue":"9","key":"741_CR60","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/01.RES.0000147315.71699.51","volume":"95","author":"E Messina","year":"2004","unstructured":"Messina E, De Angelis L, Frati G, Morrone S, Chimenti S, Fiordaliso F, et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res. 2004;95(9):911\u201321.","journal-title":"Circ Res"},{"issue":"5","key":"741_CR61","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1161\/CIRCRESAHA.109.210682","volume":"106","author":"I Chimenti","year":"2010","unstructured":"Chimenti I, Smith RR, Li TS, Gerstenblith G, Messina E, Giacomello A, et al. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ Res. 2010;106(5):971\u201380.","journal-title":"Circ Res"},{"issue":"5","key":"741_CR62","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.stemcr.2014.04.006","volume":"2","author":"AG Ibrahim","year":"2014","unstructured":"Ibrahim AG, Cheng K, Marb\u00e1n E. Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Reports. 2014;2(5):606\u201319.","journal-title":"Stem Cell Reports."},{"issue":"23","key":"741_CR63","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1089\/scd.2020.0133","volume":"29","author":"Z Ren","year":"2020","unstructured":"Ren Z, Qi Y, Sun S, Tao Y, Shi R. Mesenchymal stem cell-derived exosomes: hope for spinal cord injury repair. Stem Cells Dev. 2020;29(23):1467\u201378.","journal-title":"Stem Cells Dev."},{"key":"741_CR64","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.biomaterials.2019.02.006","volume":"200","author":"S Zhang","year":"2019","unstructured":"Zhang S, Teo KYW, Chuah SJ, Lai RC, Lim SK, Toh WS. MSC exosomes alleviate temporomandibular joint osteoarthritis by attenuating inflammation and restoring matrix homeostasis. Biomaterials. 2019;200:35\u201347.","journal-title":"Biomaterials"},{"key":"741_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116632","volume":"232","author":"Z Wei","year":"2019","unstructured":"Wei Z, Qiao S, Zhao J, Liu Y, Li Q, Wei Z, et al. miRNA-181a over-expression in mesenchymal stem cell-derived exosomes influenced inflammatory response after myocardial ischemia-reperfusion injury. Life Sci. 2019;232: 116632.","journal-title":"Life Sci"},{"issue":"7","key":"741_CR66","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/cvr\/cvz040","volume":"115","author":"J Zhao","year":"2019","unstructured":"Zhao J, Li X, Hu J, Chen F, Qiao S, Sun X, et al. Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization. Cardiovasc Res. 2019;115(7):1205\u201316.","journal-title":"Cardiovasc Res"},{"issue":"18","key":"741_CR67","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1042\/CS20171167","volume":"131","author":"QQ Wu","year":"2017","unstructured":"Wu QQ, Xiao Y, Yuan Y, Ma ZG, Liao HH, Liu C, et al. Mechanisms contributing to cardiac remodelling. Clin Sci (Lond). 2017;131(18):2319\u201345.","journal-title":"Clin Sci (Lond)"},{"issue":"7","key":"741_CR68","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s11626-020-00481-2","volume":"56","author":"F Chen","year":"2020","unstructured":"Chen F, Li X, Zhao J, Geng J, Xie J, Xu B. Bone marrow mesenchymal stem cell-derived exosomes attenuate cardiac hypertrophy and fibrosis in pressure overload induced remodeling. In Vitro Cell Dev Biol Anim. 2020;56(7):567\u201376.","journal-title":"In Vitro Cell Dev Biol Anim"},{"issue":"10","key":"741_CR69","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.5966\/sctm.2015-0367","volume":"5","author":"S Fang","year":"2016","unstructured":"Fang S, Xu C, Zhang Y, Xue C, Yang C, Bi H, et al. Umbilical cord-derived mesenchymal stem cell-derived exosomal MicroRNAs suppress myofibroblast differentiation by inhibiting the transforming growth factor-\u03b2\/SMAD2 pathway during wound healing. Stem Cells Transl Med. 2016;5(10):1425\u201339.","journal-title":"Stem Cells Transl Med"},{"issue":"2","key":"741_CR70","doi-asserted-by":"publisher","first-page":"H1308","DOI":"10.1152\/ajpheart.01277.2006","volume":"293","author":"DK Singla","year":"2007","unstructured":"Singla DK, Lyons GE, Kamp TJ. Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling. Am J Physiol Heart Circ Physiol. 2007;293(2):H1308\u201314.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"741_CR71","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s13287-024-03782-5","volume":"15","author":"M Taherian","year":"2024","unstructured":"Taherian M, Bayati P, Mojtabavi N. Stem cell-based therapy for fibrotic diseases: mechanisms and pathways. Stem Cell Res Ther. 2024;15(1):170.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"741_CR72","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13578-024-01211-x","volume":"14","author":"R Bryl","year":"2024","unstructured":"Bryl R, Kulus M, Bryja A, Domaga\u0142a D, Mozdziak P, Antosik P, et al. Cardiac progenitor cell therapy: mechanisms of action. Cell Biosci. 2024;14(1):30.","journal-title":"Cell Biosci"},{"key":"741_CR73","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fcvm.2019.00052","volume":"6","author":"TCL Bracco Gartner","year":"2019","unstructured":"Bracco Gartner TCL, Deddens JC, Mol EA, Magin Ferrer M, van Laake LW, Bouten CVC, et al. Anti-fibrotic effects of cardiac progenitor cells in a 3D-model of human cardiac fibrosis. Front Cardiovasc Med. 2019;6:52.","journal-title":"Front Cardiovasc Med."},{"key":"741_CR74","doi-asserted-by":"publisher","first-page":"5911","DOI":"10.2147\/IJN.S249129","volume":"15","author":"J Yang","year":"2020","unstructured":"Yang J, Chen Z, Pan D, Li H, Shen J. Umbilical cord-derived mesenchymal stem cell-derived exosomes combined pluronic F127 hydrogel promote chronic diabetic wound healing and complete skin regeneration. Int J Nanomedicine. 2020;15:5911\u201326.","journal-title":"Int J Nanomedicine"},{"issue":"6","key":"741_CR75","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1161\/CIRCRESAHA.117.310803","volume":"121","author":"A Tachibana","year":"2017","unstructured":"Tachibana A, Santoso MR, Mahmoudi M, Shukla P, Wang L, Bennett M, et al. Paracrine effects of the pluripotent stem cell-derived cardiac myocytes salvage the injured myocardium. Circ Res. 2017;121(6):e22\u201336.","journal-title":"Circ Res"},{"issue":"16","key":"741_CR76","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1161\/CIRCULATIONAHA.117.030785","volume":"137","author":"L Gao","year":"2018","unstructured":"Gao L, Gregorich ZR, Zhu W, Mattapally S, Oduk Y, Lou X, et al. Large cardiac muscle patches engineered from human induced-pluripotent stem cell-derived cardiac cells improve recovery from myocardial infarction in swine. Circulation. 2018;137(16):1712\u201330.","journal-title":"Circulation"},{"issue":"11","key":"741_CR77","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","volume":"16","author":"BA Teicher","year":"2010","unstructured":"Teicher BA, Fricker SP. CXCL12 (SDF-1)\/CXCR4 pathway in cancer. Clin Cancer Res. 2010;16(11):2927\u201331.","journal-title":"Clin Cancer Res"},{"key":"741_CR78","doi-asserted-by":"publisher","first-page":"1128134","DOI":"10.3389\/fcell.2023.1128134","volume":"11","author":"M Hassanpour","year":"2023","unstructured":"Hassanpour M, Salybekov AA, Kobayashi S, Asahara T. CD34 positive cells as endothelial progenitor cells in biology and medicine. Front Cell Dev Biol. 2023;11:1128134.","journal-title":"Front Cell Dev Biol."},{"key":"741_CR79","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/cells12131778","volume":"12","author":"G Tossetta","year":"2023","unstructured":"Tossetta G, Piani F, Borghi C, Marzioni D. Role of CD93 in health and disease. Cells. 2023;12:13.","journal-title":"Cells"},{"issue":"9","key":"741_CR80","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1111\/jcmm.13097","volume":"21","author":"QL Wang","year":"2017","unstructured":"Wang QL, Wang HJ, Li ZH, Wang YL, Wu XP, Tan YZ. Mesenchymal stem cell-loaded cardiac patch promotes epicardial activation and repair of the infarcted myocardium. J Cell Mol Med. 2017;21(9):1751\u201366.","journal-title":"J Cell Mol Med"},{"key":"741_CR81","doi-asserted-by":"publisher","first-page":"26298","DOI":"10.1038\/srep26298","volume":"6","author":"BC Lee","year":"2016","unstructured":"Lee BC, Kim HS, Shin TH, Kang I, Lee JY, Kim JJ, et al. PGE2 maintains self-renewal of human adult stem cells via EP2-mediated autocrine signaling and its production is regulated by cell-to-cell contact. Sci Rep. 2016;6:26298.","journal-title":"Sci Rep"},{"issue":"4","key":"741_CR82","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/jcb.20462","volume":"95","author":"H Mayer","year":"2005","unstructured":"Mayer H, Bertram H, Lindenmaier W, Korff T, Weber H, Weich H. Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation. J Cell Biochem. 2005;95(4):827\u201339.","journal-title":"J Cell Biochem"},{"issue":"1","key":"741_CR83","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.bbrc.2014.01.084","volume":"445","author":"YW Eom","year":"2014","unstructured":"Eom YW, Oh JE, Lee JI, Baik SK, Rhee KJ, Shin HC, et al. The role of growth factors in maintenance of stemness in bone marrow-derived mesenchymal stem cells. Biochem Biophys Res Commun. 2014;445(1):16\u201322.","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"741_CR84","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1096\/fj.14-250159","volume":"28","author":"CA Dumitru","year":"2014","unstructured":"Dumitru CA, Hemeda H, Jakob M, Lang S, Brandau S. Stimulation of mesenchymal stromal cells (MSCs) via TLR3 reveals a novel mechanism of autocrine priming. Faseb j. 2014;28(9):3856\u201366.","journal-title":"Faseb j"},{"issue":"3","key":"741_CR85","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.stem.2009.02.001","volume":"4","author":"JM Karp","year":"2009","unstructured":"Karp JM, Leng Teo GS. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell. 2009;4(3):206\u201316.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"741_CR86","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13287-017-0472-y","volume":"8","author":"C Mao","year":"2017","unstructured":"Mao C, Hou X, Wang B, Chi J, Jiang Y, Zhang C, et al. Intramuscular injection of human umbilical cord-derived mesenchymal stem cells improves cardiac function in dilated cardiomyopathy rats. Stem Cell Res Ther. 2017;8(1):18.","journal-title":"Stem Cell Res Ther"},{"key":"741_CR87","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-3-319-57613-8_5","volume":"1003","author":"T Kennedy-Lydon","year":"2017","unstructured":"Kennedy-Lydon T. Immune functions and properties of resident cells in the heart and cardiovascular system: pericytes. Adv Exp Med Biol. 2017;1003:93\u2013103.","journal-title":"Adv Exp Med Biol"},{"issue":"23","key":"741_CR88","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1016\/j.jacc.2013.02.071","volume":"61","author":"J Bartunek","year":"2013","unstructured":"Bartunek J, Behfar A, Dolatabadi D, Vanderheyden M, Ostojic M, Dens J, et al. Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. J Am Coll Cardiol. 2013;61(23):2329\u201338.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"741_CR89","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.16236","volume":"3","author":"X He","year":"2020","unstructured":"He X, Wang Q, Zhao Y, Zhang H, Wang B, Pan J, et al. Effect of intramyocardial grafting collagen scaffold with mesenchymal stromal cells in patients with chronic ischemic heart disease: a randomized clinical trial. JAMA Netw Open. 2020;3(9): e2016236.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"741_CR90","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/jama.2013.282909","volume":"311","author":"AW Heldman","year":"2014","unstructured":"Heldman AW, DiFede DL, Fishman JE, Zambrano JP, Trachtenberg BH, Karantalis V, et al. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. JAMA. 2014;311(1):62\u201373.","journal-title":"JAMA"},{"issue":"27","key":"741_CR91","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1093\/eurheartj\/ehv136","volume":"36","author":"AB Mathiasen","year":"2015","unstructured":"Mathiasen AB, Qayyum AA, J\u00f8rgensen E, Helqvist S, Fischer-Nielsen A, Kofoed KF, et al. Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial). Eur Heart J. 2015;36(27):1744\u201353.","journal-title":"Eur Heart J"},{"issue":"5","key":"741_CR92","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/ejhf.1700","volume":"22","author":"AB Mathiasen","year":"2020","unstructured":"Mathiasen AB, Qayyum AA, J\u00f8rgensen E, Helqvist S, Kofoed KF, Haack-S\u00f8rensen M, et al. Bone marrow-derived mesenchymal stromal cell treatment in patients with ischaemic heart failure: final 4-year follow-up of the MSC-HF trial. Eur J Heart Fail. 2020;22(5):884\u201392.","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"741_CR93","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1161\/CIRCRESAHA.117.310712","volume":"121","author":"J Bartolucci","year":"2017","unstructured":"Bartolucci J, Verdugo FJ, Gonz\u00e1lez PL, Larrea RE, Abarzua E, Goset C, et al. Safety and efficacy of the intravenous infusion of umbilical cord mesenchymal stem cells in patients with heart failure: a phase 1\/2 randomized controlled trial (RIMECARD trial [randomized clinical trial of intravenous infusion umbilical cord mesenchymal stem cells on cardiopathy]). Circ Res. 2017;121(10):1192\u2013204.","journal-title":"Circ Res"},{"issue":"10036","key":"741_CR94","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1016\/S0140-6736(16)30137-4","volume":"387","author":"AN Patel","year":"2016","unstructured":"Patel AN, Henry TD, Quyyumi AA, Schaer GL, Anderson RD, Toma C, et al. Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial. Lancet. 2016;387(10036):2412\u201321.","journal-title":"Lancet"},{"issue":"22","key":"741_CR95","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1001\/jama.2012.25321","volume":"308","author":"JM Hare","year":"2012","unstructured":"Hare JM, Fishman JE, Gerstenblith G, DiFede Velazquez DL, Zambrano JP, Suncion VY, et al. Comparison of allogeneic vs autologous bone marrow\u2013derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA. 2012;308(22):2369\u201379.","journal-title":"JAMA"},{"issue":"22","key":"741_CR96","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1161\/CIRCULATIONAHA.113.007412","volume":"129","author":"DD Ascheim","year":"2014","unstructured":"Ascheim DD, Gelijns AC, Goldstein D, Moye LA, Smedira N, Lee S, et al. Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices. Circulation. 2014;129(22):2287\u201396.","journal-title":"Circulation"},{"issue":"12","key":"741_CR97","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1001\/jama.2019.2341","volume":"321","author":"TM Yau","year":"2019","unstructured":"Yau TM, Pagani FD, Mancini DM, Chang HL, Lala A, Woo YJ, et al. Intramyocardial injection of mesenchymal precursor cells and successful temporary weaning from left ventricular assist device support in patients with advanced heart failure: a randomized clinical trial. JAMA. 2019;321(12):1176\u201386.","journal-title":"JAMA"},{"issue":"9","key":"741_CR98","first-page":"648","volume":"38","author":"J Bartunek","year":"2017","unstructured":"Bartunek J, Terzic A, Davison BA, Filippatos GS, Radovanovic S, Beleslin B, et al. Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial. Eur Heart J. 2017;38(9):648\u201360.","journal-title":"Eur Heart J"},{"issue":"11","key":"741_CR99","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1002\/ejhf.898","volume":"19","author":"JR Teerlink","year":"2017","unstructured":"Teerlink JR, Metra M, Filippatos GS, Davison BA, Bartunek J, Terzic A, et al. Benefit of cardiopoietic mesenchymal stem cell therapy on left ventricular remodelling: results from the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) study. Eur J Heart Fail. 2017;19(11):1520\u20139.","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"741_CR100","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jacc.2022.11.061","volume":"81","author":"EC Perin","year":"2023","unstructured":"Perin EC, Borow KM, Henry TD, Mendelsohn FO, Miller LW, Swiggum E, et al. Randomized trial of targeted transendocardial mesenchymal precursor cell therapy in patients with heart failure. J Am Coll Cardiol. 2023;81(9):849\u201363.","journal-title":"J Am Coll Cardiol"},{"key":"741_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105060","volume":"102","author":"A Bayes-Genis","year":"2024","unstructured":"Bayes-Genis A, Gastelurrutia P, Mongui\u00f3-Tortajada M, C\u00e1mara ML, Prat-Vidal C, Cediel G, et al. Implantation of a double allogeneic human engineered tissue graft on damaged heart: insights from the PERISCOPE phase I clinical trial. EBioMedicine. 2024;102: 105060.","journal-title":"EBioMedicine"},{"issue":"2","key":"741_CR102","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1002\/ehf2.14281","volume":"10","author":"AA Qayyum","year":"2023","unstructured":"Qayyum AA, Mouridsen M, Nilsson B, Gustafsson I, Schou M, Nielsen OW, et al. Danish phase II trial using adipose tissue derived mesenchymal stromal cells for patients with ischaemic heart failure. ESC Heart Fail. 2023;10(2):1170\u201383.","journal-title":"ESC Heart Fail."},{"issue":"4","key":"741_CR103","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/ejhf.2772","volume":"25","author":"AA Qayyum","year":"2023","unstructured":"Qayyum AA, van Klarenbosch B, Frljak S, Cerar A, Poglajen G, Traxler-Weidenauer D, et al. Effect of allogeneic adipose tissue-derived mesenchymal stromal cell treatment in chronic ischaemic heart failure with reduced ejection fraction - the SCIENCE trial. Eur J Heart Fail. 2023;25(4):576\u201387.","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"741_CR104","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jacc.2014.10.040","volume":"65","author":"S Golpanian","year":"2015","unstructured":"Golpanian S, El-Khorazaty J, Mendizabal A, DiFede DL, Suncion VY, Karantalis V, et al. Effect of aging on human mesenchymal stem cell therapy in ischemic cardiomyopathy patients. J Am Coll Cardiol. 2015;65(2):125\u201332.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"741_CR105","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1161\/CIRCRESAHA.116.309281","volume":"119","author":"KE Hatzistergos","year":"2016","unstructured":"Hatzistergos KE, Saur D, Seidler B, Balkan W, Breton M, Valasaki K, et al. Stimulatory effects of mesenchymal stem cells on cKit+ cardiac stem cells are mediated by SDF1\/CXCR4 and SCF\/cKit signaling pathways. Circ Res. 2016;119(8):921\u201330.","journal-title":"Circ Res"},{"issue":"4","key":"741_CR106","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/ejhf.2178","volume":"23","author":"R Bolli","year":"2021","unstructured":"Bolli R, Mitrani RD, Hare JM, Pepine CJ, Perin EC, Willerson JT, et al. A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial. Eur J Heart Fail. 2021;23(4):661\u201374.","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"741_CR107","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1161\/CIRCRESAHA.117.311827","volume":"121","author":"V Florea","year":"2017","unstructured":"Florea V, Rieger AC, DiFede DL, El-Khorazaty J, Natsumeda M, Banerjee MN, et al. Dose comparison study of allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy (The TRIDENT Study). Circ Res. 2017;121(11):1279\u201390.","journal-title":"Circ Res"},{"issue":"2","key":"741_CR108","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s12265-009-9145-2","volume":"3","author":"S Mansour","year":"2010","unstructured":"Mansour S, Roy DC, Bouchard V, Nguyen BK, Stevens LM, Gobeil F, et al. COMPARE-AMI trial: comparison of intracoronary injection of CD133+ bone marrow stem cells to placebo in patients after acute myocardial infarction and left ventricular dysfunction: study rationale and design. J Cardiovasc Transl Res. 2010;3(2):153\u20139.","journal-title":"J Cardiovasc Transl Res"},{"issue":"1","key":"741_CR109","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/MCA.0000000000000302","volume":"27","author":"F Qiu","year":"2016","unstructured":"Qiu F, Maehara A, El Khoury R, G\u00e9n\u00e9reux P, LaSalle L, Mintz GS, et al. Impact of intracoronary injection of CD133+ bone marrow stem cells on coronary atherosclerotic progression in patients with STEMI: a COMPARE-AMI IVUS substudy. Coron Artery Dis. 2016;27(1):5\u201312.","journal-title":"Coron Artery Dis"},{"issue":"2","key":"741_CR110","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.carrev.2009.04.001","volume":"11","author":"R Flores-Ram\u00edrez","year":"2010","unstructured":"Flores-Ram\u00edrez R, Uribe-Longoria A, Rangel-Fuentes MM, Guti\u00e9rrez-Fajardo P, Salazar-Riojas R, Cervantes-Garc\u00eda D, et al. Intracoronary infusion of CD133+ endothelial progenitor cells improves heart function and quality of life in patients with chronic post-infarct heart insufficiency. Cardiovasc Revasc Med. 2010;11(2):72\u20138.","journal-title":"Cardiovasc Revasc Med"},{"issue":"6","key":"741_CR111","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.jtcvs.2016.07.067","volume":"152","author":"N Noiseux","year":"2016","unstructured":"Noiseux N, Mansour S, Weisel R, Stevens LM, Der Sarkissian S, Tsang K, et al. The IMPACT-CABG trial: a multicenter, randomized clinical trial of CD133(+) stem cell therapy during coronary artery bypass grafting for ischemic cardiomyopathy. J Thorac Cardiovasc Surg. 2016;152(6):1582-8.e2.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"741_CR112","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/jocs.14454","volume":"35","author":"TW Soetisna","year":"2020","unstructured":"Soetisna TW, Sukmawan R, Setianto B, Mansyur M, Murni TW, Listiyaningsih E, et al. Combined transepicardial and transseptal implantation of autologous CD 133+ bone marrow cells during bypass grafting improves cardiac function in patients with low ejection fraction. J Card Surg. 2020;35(4):740\u20136.","journal-title":"J Card Surg"},{"issue":"9429","key":"741_CR113","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0140-6736(04)16626-9","volume":"364","author":"KC Wollert","year":"2004","unstructured":"Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet. 2004;364(9429):141\u20138.","journal-title":"Lancet"},{"issue":"39","key":"741_CR114","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1093\/eurheartj\/ehx188","volume":"38","author":"KC Wollert","year":"2017","unstructured":"Wollert KC, Meyer GP, M\u00fcller-Ehmsen J, Tsch\u00f6pe C, Bonarjee V, Larsen AI, et al. Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial. Eur Heart J. 2017;38(39):2936\u201343.","journal-title":"Eur Heart J"},{"issue":"3","key":"741_CR115","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/eurheartj\/ehv493","volume":"37","author":"F Choudry","year":"2016","unstructured":"Choudry F, Hamshere S, Saunders N, Veerapen J, Bavnbek K, Knight C, et al. A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trial\u2020. Eur Heart J. 2016;37(3):256\u201363.","journal-title":"Eur Heart J"},{"issue":"2","key":"741_CR116","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1002\/ehf2.13786","volume":"9","author":"A Mathur","year":"2022","unstructured":"Mathur A, Sim DS, Choudry F, Veerapen J, Colicchia M, Turlejski T, et al. Five-year follow-up of intracoronary autologous cell therapy in acute myocardial infarction: the REGENERATE-AMI trial. ESC Heart Fail. 2022;9(2):1152\u20139.","journal-title":"ESC Heart Fail."},{"issue":"2","key":"741_CR117","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1161\/CIRCRESAHA.115.308165","volume":"120","author":"AA Quyyumi","year":"2017","unstructured":"Quyyumi AA, Vasquez A, Kereiakes DJ, Klapholz M, Schaer GL, Abdel-Latif A, et al. PreSERVE-AMI: a randomized, double-blind, placebo-controlled clinical trial of intracoronary administration of autologous CD34+ cells in patients with left ventricular dysfunction post STEMI. Circ Res. 2017;120(2):324\u201331.","journal-title":"Circ Res"},{"issue":"9505","key":"741_CR118","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0140-6736(05)67861-0","volume":"367","author":"S Janssens","year":"2006","unstructured":"Janssens S, Dubois C, Bogaert J, Theunissen K, Deroose C, Desmet W, et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet. 2006;367(9505):113\u201321.","journal-title":"Lancet"},{"issue":"19","key":"741_CR119","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1093\/eurheartj\/ehu007","volume":"35","author":"BA Nasseri","year":"2014","unstructured":"Nasseri BA, Ebell W, Dandel M, Kukucka M, Gebker R, Doltra A, et al. Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the Cardio133 trial. Eur Heart J. 2014;35(19):1263\u201374.","journal-title":"Eur Heart J"},{"issue":"4","key":"741_CR120","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jacc.2017.11.047","volume":"71","author":"P Menasch\u00e9","year":"2018","unstructured":"Menasch\u00e9 P, Vanneaux V, Hag\u00e8ge A, Bel A, Cholley B, Parouchev A, et al. Transplantation of human embryonic stem cell-derived cardiovascular progenitors for severe ischemic left ventricular dysfunction. J Am Coll Cardiol. 2018;71(4):429\u201338.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"741_CR121","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.healun.2016.01.013","volume":"35","author":"A Kervadec","year":"2016","unstructured":"Kervadec A, Bellamy V, El Harane N, Arak\u00e9lian L, Vanneaux V, Cacciapuoti I, et al. Cardiovascular progenitor-derived extracellular vesicles recapitulate the beneficial effects of their parent cells in the treatment of chronic heart failure. J Heart Lung Transplant. 2016;35(6):795\u2013807.","journal-title":"J Heart Lung Transplant"},{"key":"741_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105145","volume":"103","author":"P Menasch\u00e9","year":"2024","unstructured":"Menasch\u00e9 P, Renault NK, Hag\u00e8ge A, Puscas T, Bellamy V, Humbert C, et al. First-in-man use of a cardiovascular cell-derived secretome in heart failure. Case report. EBioMedicine. 2024;103: 105145.","journal-title":"EBioMedicine"},{"issue":"10","key":"741_CR123","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1093\/eurheartj\/ehr018","volume":"32","author":"J Tongers","year":"2011","unstructured":"Tongers J, Losordo DW, Landmesser U. Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges. Eur Heart J. 2011;32(10):1197\u2013206.","journal-title":"Eur Heart J"},{"issue":"3","key":"741_CR124","first-page":"201","volume":"38","author":"R Gallet","year":"2017","unstructured":"Gallet R, Dawkins J, Valle J, Simsolo E, de Couto G, Middleton R, et al. Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction. Eur Heart J. 2017;38(3):201\u201311.","journal-title":"Eur Heart J"},{"key":"741_CR125","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.895322","volume":"13","author":"S Yedavilli","year":"2022","unstructured":"Yedavilli S, Singh AD, Singh D, Samal R. Nano-messengers of the heart: promising theranostic candidates for cardiovascular maladies. Front Physiol. 2022;13: 895322.","journal-title":"Front Physiol"},{"issue":"5","key":"741_CR126","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1007\/s12015-021-10168-0","volume":"17","author":"S Gupta","year":"2021","unstructured":"Gupta S, Sharma A, Verma RS. Mesenchymal stem cells for cardiac regeneration: from differentiation to cell delivery. Stem Cell Rev Rep. 2021;17(5):1666\u201394.","journal-title":"Stem Cell Rev Rep."},{"issue":"2","key":"741_CR127","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201801011","volume":"8","author":"K Huang","year":"2019","unstructured":"Huang K, Hu S, Cheng K. A new era of cardiac cell therapy: opportunities and challenges. Adv Healthc Mater. 2019;8(2): e1801011.","journal-title":"Adv Healthc Mater."},{"issue":"5","key":"741_CR128","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1016\/j.athoracsur.2012.11.020","volume":"95","author":"A Cannata","year":"2013","unstructured":"Cannata A, Petrella D, Russo CF, Bruschi G, Fratto P, Gambacorta M, et al. Postsurgical intrapericardial adhesions: mechanisms of formation and prevention. Ann Thorac Surg. 2013;95(5):1818\u201326.","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"741_CR129","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1021\/acs.accounts.9b00137","volume":"52","author":"Z Li","year":"2019","unstructured":"Li Z, Hu S, Cheng K. Chemical engineering of cell therapy for heart diseases. Acc Chem Res. 2019;52(6):1687\u201396.","journal-title":"Acc Chem Res"},{"key":"741_CR130","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.yjmcc.2022.11.004","volume":"174","author":"H Kobayashi","year":"2023","unstructured":"Kobayashi H, Tohyama S, Kanazawa H, Ichimura H, Chino S, Tanaka Y, et al. Intracoronary transplantation of pluripotent stem cell-derived cardiomyocytes: Inefficient procedure for cardiac regeneration. J Mol Cell Cardiol. 2023;174:77\u201387.","journal-title":"J Mol Cell Cardiol"},{"key":"741_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173049","volume":"876","author":"Z Liu","year":"2020","unstructured":"Liu Z, Mikrani R, Zubair HM, Taleb A, Naveed M, Baig M, et al. Systemic and local delivery of mesenchymal stem cells for heart renovation: challenges and innovations. Eur J Pharmacol. 2020;876: 173049.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"741_CR132","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.cardiores.2005.04.011","volume":"67","author":"J Dow","year":"2005","unstructured":"Dow J, Simkhovich BZ, Kedes L, Kloner RA. Washout of transplanted cells from the heart: a potential new hurdle for cell transplantation therapy. Cardiovasc Res. 2005;67(2):301\u20137.","journal-title":"Cardiovasc Res"},{"issue":"3","key":"741_CR133","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1021\/acs.accounts.7b00526","volume":"51","author":"Z Chen","year":"2018","unstructured":"Chen Z, Hu Q, Gu Z. Leveraging engineering of cells for drug delivery. Acc Chem Res. 2018;51(3):668\u201377.","journal-title":"Acc Chem Res"},{"issue":"10","key":"741_CR134","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1021\/ar200044b","volume":"44","author":"J Xie","year":"2011","unstructured":"Xie J, Liu G, Eden HS, Ai H, Chen X. Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapy. Acc Chem Res. 2011;44(10):883\u201392.","journal-title":"Acc Chem Res"},{"issue":"10","key":"741_CR135","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1021\/ar200085c","volume":"44","author":"D Yoo","year":"2011","unstructured":"Yoo D, Lee JH, Shin TH, Cheon J. Theranostic magnetic nanoparticles. Acc Chem Res. 2011;44(10):863\u201374.","journal-title":"Acc Chem Res"},{"key":"741_CR136","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.biomaterials.2017.11.012","volume":"155","author":"A Ottersbach","year":"2018","unstructured":"Ottersbach A, Mykhaylyk O, Heidsieck A, Eberbeck D, Rieck S, Zimmermann K, et al. Improved heart repair upon myocardial infarction: combination of magnetic nanoparticles and tailored magnets strongly increases engraftment of myocytes. Biomaterials. 2018;155:176\u201390.","journal-title":"Biomaterials"},{"issue":"10","key":"741_CR137","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.5966\/sctm.2015-0220","volume":"5","author":"J Wang","year":"2016","unstructured":"Wang J, Xiang B, Deng J, Lin HY, Zheng D, Freed DH, et al. Externally applied static magnetic field enhances cardiac retention and functional benefit of magnetically iron-labeled adipose-derived stem cells in infarcted hearts. Stem Cells Transl Med. 2016;5(10):1380\u201393.","journal-title":"Stem Cells Transl Med"},{"key":"741_CR138","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41551-017-0182-x","volume":"2","author":"J Tang","year":"2018","unstructured":"Tang J, Su T, Huang K, Dinh PU, Wang Z, Vandergriff A, et al. Targeted repair of heart injury by stem cells fused with platelet nanovesicles. Nat Biomed Eng. 2018;2:17\u201326.","journal-title":"Nat Biomed Eng."},{"key":"741_CR139","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/960926","volume":"2015","author":"AC Vandergriff","year":"2015","unstructured":"Vandergriff AC, de Andrade JB, Tang J, Hensley MT, Piedrahita JA, Caranasos TG, et al. Intravenous cardiac stem cell-derived exosomes ameliorate cardiac dysfunction in doxorubicin induced dilated cardiomyopathy. Stem Cells Int. 2015;2015: 960926.","journal-title":"Stem Cells Int."},{"issue":"7","key":"741_CR140","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.7150\/thno.20524","volume":"8","author":"A Vandergriff","year":"2018","unstructured":"Vandergriff A, Huang K, Shen D, Hu S, Hensley MT, Caranasos TG, et al. Targeting regenerative exosomes to myocardial infarction using cardiac homing peptide. Theranostics. 2018;8(7):1869\u201378.","journal-title":"Theranostics."},{"key":"741_CR141","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/ijms21207701","volume":"21","author":"A Mancuso","year":"2020","unstructured":"Mancuso A, Barone A, Cristiano MC, Cianflone E, Fresta M, Paolino D. Cardiac stem cell-loaded delivery systems: a new challenge for myocardial tissue regeneration. Int J Mol Sci. 2020;21:20.","journal-title":"Int J Mol Sci"},{"key":"741_CR142","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/polym16131878","volume":"16","author":"R Patel","year":"2024","unstructured":"Patel R, Patel D. Injectable hydrogels in cardiovascular tissue engineering. Polymers (Basel). 2024;16:13.","journal-title":"Polymers (Basel)."},{"key":"741_CR143","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.biomaterials.2014.11.004","volume":"39","author":"NJ Blackburn","year":"2015","unstructured":"Blackburn NJ, Sofrenovic T, Kuraitis D, Ahmadi A, McNeill B, Deng C, et al. Timing underpins the benefits associated with injectable collagen biomaterial therapy for the treatment of myocardial infarction. Biomaterials. 2015;39:182\u201392.","journal-title":"Biomaterials"},{"key":"741_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119289","volume":"217","author":"Y Matsumura","year":"2019","unstructured":"Matsumura Y, Zhu Y, Jiang H, D\u2019Amore A, Luketich SK, Charwat V, et al. Intramyocardial injection of a fully synthetic hydrogel attenuates left ventricular remodeling post myocardial infarction. Biomaterials. 2019;217: 119289.","journal-title":"Biomaterials"},{"issue":"5","key":"741_CR145","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s10741-020-09934-y","volume":"26","author":"S Guan","year":"2021","unstructured":"Guan S, Li J, Zhang K, Li J. Environmentally responsive hydrogels for repair of cardiovascular tissue. Heart Fail Rev. 2021;26(5):1273\u201385.","journal-title":"Heart Fail Rev"},{"key":"741_CR146","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.jconrel.2020.02.047","volume":"321","author":"TY Park","year":"2020","unstructured":"Park TY, Oh JM, Cho JS, Sim SB, Lee J, Cha HJ. Stem cell-loaded adhesive immiscible liquid for regeneration of myocardial infarction. J Control Release. 2020;321:602\u201315.","journal-title":"J Control Release"},{"issue":"10","key":"741_CR147","doi-asserted-by":"publisher","first-page":"15935","DOI":"10.1021\/acsnano.2c03060","volume":"16","author":"S Hu","year":"2022","unstructured":"Hu S, Zhu D, Li Z, Cheng K. Detachable microneedle patches deliver mesenchymal stromal cell factor-loaded nanoparticles for cardiac repair. ACS Nano. 2022;16(10):15935\u201345.","journal-title":"ACS Nano"},{"issue":"4","key":"741_CR148","doi-asserted-by":"publisher","first-page":"410","DOI":"10.5966\/sctm.2015-0288","volume":"5","author":"NT Feric","year":"2016","unstructured":"Feric NT, Radisic M. Strategies and challenges to myocardial replacement therapy. Stem Cells Transl Med. 2016;5(4):410\u20136.","journal-title":"Stem Cells Transl Med"},{"issue":"10","key":"741_CR149","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/nmat4956","volume":"16","author":"M Montgomery","year":"2017","unstructured":"Montgomery M, Ahadian S, Davenport Huyer L, Lo Rito M, Civitarese RA, Vanderlaan RD, et al. Flexible shape-memory scaffold for minimally invasive delivery of functional tissues. Nat Mater. 2017;16(10):1038\u201346.","journal-title":"Nat Mater"},{"key":"741_CR150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/bioengineering9010011","volume":"9","author":"J Li","year":"2022","unstructured":"Li J, Liu L, Zhang J, Qu X, Kawamura T, Miyagawa S, et al. Engineered tissue for cardiac regeneration: current status and future perspectives. Bioengineering (Basel). 2022;9:11.","journal-title":"Bioengineering (Basel)."},{"issue":"5","key":"741_CR151","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s13770-022-00467-z","volume":"19","author":"R Munderere","year":"2022","unstructured":"Munderere R, Kim SH, Kim C, Park SH. The progress of stem cell therapy in myocardial-infarcted heart regeneration: cell sheet technology. Tissue Eng Regen Med. 2022;19(5):969\u201386.","journal-title":"Tissue Eng Regen Med"},{"issue":"8","key":"741_CR152","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1016\/j.bbagen.2014.01.010","volume":"1840","author":"F Gattazzo","year":"2014","unstructured":"Gattazzo F, Urciuolo A, Bonaldo P. Extracellular matrix: a dynamic microenvironment for stem cell niche. Biochim Biophys Acta. 2014;1840(8):2506\u201319.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"741_CR153","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41587-019-0016-3","volume":"37","author":"T Deuse","year":"2019","unstructured":"Deuse T, Hu X, Gravina A, Wang D, Tediashvili G, De C, et al. Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients. Nat Biotechnol. 2019;37(3):252\u20138.","journal-title":"Nat Biotechnol"},{"key":"741_CR154","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1126\/scitranslmed.aax2992","volume":"12","author":"X Sun","year":"2020","unstructured":"Sun X, Wu J, Qiang B, Romagnuolo R, Gagliardi M, Keller G, et al. Transplanted microvessels improve pluripotent stem cell-derived cardiomyocyte engraftment and cardiac function after infarction in rats. Sci Transl Med. 2020;12:562.","journal-title":"Sci Transl Med."},{"issue":"5","key":"741_CR155","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1161\/CIRCRESAHA.116.308937","volume":"119","author":"Y Tokita","year":"2016","unstructured":"Tokita Y, Tang XL, Li Q, Wysoczynski M, Hong KU, Nakamura S, et al. Repeated administrations of cardiac progenitor cells are markedly more effective than a single administration: a new paradigm in cell therapy. Circ Res. 2016;119(5):635\u201351.","journal-title":"Circ Res"},{"issue":"8","key":"741_CR156","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13248","volume":"55","author":"Y Morita","year":"2022","unstructured":"Morita Y, Kishino Y, Fukuda K, Tohyama S. Scalable manufacturing of clinical-grade differentiated cardiomyocytes derived from human-induced pluripotent stem cells for regenerative therapy. Cell Prolif. 2022;55(8): e13248.","journal-title":"Cell Prolif"},{"key":"741_CR157","doi-asserted-by":"publisher","first-page":"13724","DOI":"10.1038\/ncomms13724","volume":"8","author":"J Tang","year":"2017","unstructured":"Tang J, Shen D, Caranasos TG, Wang Z, Vandergriff AC, Allen TA, et al. Therapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome. Nat Commun. 2017;8:13724.","journal-title":"Nat Commun"},{"issue":"4","key":"741_CR158","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/aps.2017.178","volume":"39","author":"SP Li","year":"2018","unstructured":"Li SP, Lin ZX, Jiang XY, Yu XY. Exosomal cargo-loading and synthetic exosome-mimics as potential therapeutic tools. Acta Pharmacol Sin. 2018;39(4):542\u201351.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"741_CR159","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40580-024-00423-8","volume":"11","author":"S Ding","year":"2024","unstructured":"Ding S, Kim YJ, Huang KY, Um D, Jung Y, Kong H. Delivery-mediated exosomal therapeutics in ischemia-reperfusion injury: advances, mechanisms, and future directions. Nano Converg. 2024;11(1):18.","journal-title":"Nano Converg."},{"issue":"1","key":"741_CR160","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/s41467-021-21682-7","volume":"12","author":"D Zhu","year":"2021","unstructured":"Zhu D, Li Z, Huang K, Caranasos TG, Rossi JS, Cheng K. Minimally invasive delivery of therapeutic agents by hydrogel injection into the pericardial cavity for cardiac repair. Nat Commun. 2021;12(1):1412.","journal-title":"Nat Commun"},{"key":"741_CR161","doi-asserted-by":"publisher","first-page":"10721","DOI":"10.1038\/srep10721","volume":"5","author":"S Bala","year":"2015","unstructured":"Bala S, Csak T, Momen-Heravi F, Lippai D, Kodys K, Catalano D, et al. Biodistribution and function of extracellular miRNA-155 in mice. Sci Rep. 2015;5:10721.","journal-title":"Sci Rep"},{"key":"741_CR162","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/ijms20030468","volume":"20","author":"A Ciullo","year":"2019","unstructured":"Ciullo A, Biemmi V, Milano G, Bolis S, Cervio E, Fertig ET, et al. Exosomal expression of CXCR4 targets cardioprotective vesicles to myocardial infarction and improves outcome after systemic administration. Int J Mol Sci. 2019;20:3.","journal-title":"Int J Mol Sci"},{"key":"741_CR163","doi-asserted-by":"crossref","unstructured":"Ong CS, Fukunishi T, Nashed A, Blazeski A, Zhang H, Hardy S, et al. Creation of cardiac tissue exhibiting mechanical integration of spheroids using 3D bioprinting. J Vis Exp. 2017;125.","DOI":"10.3791\/55438"},{"issue":"5","key":"741_CR164","first-page":"1388","volume":"6","author":"N Liu","year":"2021","unstructured":"Liu N, Ye X, Yao B, Zhao M, Wu P, Liu G, et al. Advances in 3D bioprinting technology for cardiac tissue engineering and regeneration. Bioact Mater. 2021;6(5):1388\u2013401.","journal-title":"Bioact Mater."},{"key":"741_CR165","doi-asserted-by":"publisher","first-page":"6497242","DOI":"10.1155\/2018\/6497242","volume":"2018","author":"CS Ong","year":"2018","unstructured":"Ong CS, Nam L, Ong K, Krishnan A, Huang CY, Fukunishi T, et al. 3D and 4D bioprinting of the myocardium: current approaches, challenges, and future prospects. Biomed Res Int. 2018;2018:6497242.","journal-title":"Biomed Res Int"},{"issue":"1","key":"741_CR166","doi-asserted-by":"publisher","first-page":"13532","DOI":"10.1038\/s41598-018-31848-x","volume":"8","author":"F Maiullari","year":"2018","unstructured":"Maiullari F, Costantini M, Milan M, Pace V, Chiriv\u00ec M, Maiullari S, et al. A multi-cellular 3D bioprinting approach for vascularized heart tissue engineering based on HUVECs and iPSC-derived cardiomyocytes. Sci Rep. 2018;8(1):13532.","journal-title":"Sci Rep"},{"key":"741_CR167","doi-asserted-by":"crossref","unstructured":"Chingale M, Cheng K, Huang K. 3D bioprinting technology\u2014one step closer towards cardiac tissue regeneration. Front Mater. 2022;8:2021.","DOI":"10.3389\/fmats.2021.804134"},{"issue":"8","key":"741_CR168","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.jcyt.2014.01.417","volume":"16","author":"PJ Hanley","year":"2014","unstructured":"Hanley PJ, Mei Z, Durett AG, Cabreira-Hansen Mda G, Klis M, Li W, et al. Efficient manufacturing of therapeutic mesenchymal stromal cells with the use of the quantum cell expansion system. Cytotherapy. 2014;16(8):1048\u201358.","journal-title":"Cytotherapy"},{"issue":"2","key":"741_CR169","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s12015-024-10812-5","volume":"21","author":"M Strecanska","year":"2025","unstructured":"Strecanska M, Sekelova T, Smolinska V, Kuniakova M, Nicodemou A. Automated manufacturing processes and platforms for large-scale production of clinical-grade mesenchymal stem\/ stromal cells. Stem Cell Rev Rep. 2025;21(2):372\u201389.","journal-title":"Stem Cell Rev Rep."},{"issue":"2","key":"741_CR170","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.scr.2015.08.002","volume":"15","author":"VC Chen","year":"2015","unstructured":"Chen VC, Ye J, Shukla P, Hua G, Chen D, Lin Z, et al. Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells. Stem Cell Res. 2015;15(2):365\u201375.","journal-title":"Stem Cell Res"},{"key":"741_CR171","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.omtm.2022.05.010","volume":"26","author":"Y Kitano","year":"2022","unstructured":"Kitano Y, Nishimura S, Kato TM, Ueda A, Takigawa K, Umekage M, et al. Generation of hypoimmunogenic induced pluripotent stem cells by CRISPR-Cas9 system and detailed evaluation for clinical application. Mol Ther Methods Clin Dev. 2022;26:15\u201325.","journal-title":"Mol Ther Methods Clin Dev."},{"issue":"21","key":"741_CR172","doi-asserted-by":"publisher","first-page":"10441","DOI":"10.1073\/pnas.1902566116","volume":"116","author":"X Han","year":"2019","unstructured":"Han X, Wang M, Duan S, Franco PJ, Kenty JH, Hedrick P, et al. Generation of hypoimmunogenic human pluripotent stem cells. Proc Natl Acad Sci U S A. 2019;116(21):10441\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"741_CR173","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s13287-024-03810-4","volume":"15","author":"N Tsuneyoshi","year":"2024","unstructured":"Tsuneyoshi N, Hosoya T, Takeno Y, Saitoh K, Murai H, Amimoto N, et al. Hypoimmunogenic human iPSCs expressing HLA-G, PD-L1, and PD-L2 evade innate and adaptive immunity. Stem Cell Res Ther. 2024;15(1):193.","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"741_CR174","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.stemcr.2022.02.008","volume":"17","author":"D Simkin","year":"2022","unstructured":"Simkin D, Papakis V, Bustos BI, Ambrosi CM, Ryan SJ, Baru V, et al. Homozygous might be hemizygous: CRISPR\/Cas9 editing in iPSCs results in detrimental on-target defects that escape standard quality controls. Stem Cell Rep. 2022;17(4):993\u20131008.","journal-title":"Stem Cell Rep."},{"issue":"1","key":"741_CR175","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1161\/CIRCRESAHA.116.304872","volume":"116","author":"O Jansen","year":"2015","unstructured":"Jansen O, Lorkeers SJ, Eding JE, Vesterinen HM, van der Spoel TI, Sena ES, Duckers HJ, et al. Similar effect of autologous and allogeneic cell therapy for ischemic heart disease: systematic review and meta-analysis of large animal studies. Circ Res. 2015;116(1):80\u20136.","journal-title":"Circ Res"},{"key":"741_CR176","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s13287-015-0233-8","volume":"6","author":"N Ketterl","year":"2015","unstructured":"Ketterl N, Brachtl G, Schuh C, Bieback K, Schallmoser K, Reinisch A, et al. A robust potency assay highlights significant donor variation of human mesenchymal stem\/progenitor cell immune modulatory capacity and extended radio-resistance. Stem Cell Res Ther. 2015;6:236.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"741_CR177","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13578-021-00698-y","volume":"11","author":"C Li","year":"2021","unstructured":"Li C, Zhao H, Cheng L, Wang B. Allogeneic vs. autologous mesenchymal stem\/stromal cells in their medication practice. Cell Biosci. 2021;11(1):187.","journal-title":"Cell Biosci"},{"issue":"12","key":"741_CR178","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1016\/j.stemcr.2023.10.016","volume":"18","author":"W Zhu","year":"2023","unstructured":"Zhu W, Li M, Zou J, Zhang D, Fang M, Sun Y, et al. Induction of local immunosuppression in allogeneic cell transplantation by cell-type-specific expression of PD-L1 and CTLA4Ig. Stem Cell Rep. 2023;18(12):2344\u201355.","journal-title":"Stem Cell Rep."},{"key":"741_CR179","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.901661","volume":"10","author":"IS Hong","year":"2022","unstructured":"Hong IS. Enhancing stem cell-based therapeutic potential by combining various bioengineering technologies. Front Cell Dev Biol. 2022;10: 901661.","journal-title":"Front Cell Dev Biol."},{"issue":"1","key":"741_CR180","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41421-023-00543-1","volume":"9","author":"X Yang","year":"2023","unstructured":"Yang X, Chen D, Sun Q, Wang Y, Xia Y, Yang J, et al. A live-cell image-based machine learning strategy for reducing variability in PSC differentiation systems. Cell Discov. 2023;9(1):53.","journal-title":"Cell Discov."},{"key":"741_CR181","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ebiom.2017.07.022","volume":"22","author":"G Steinhoff","year":"2017","unstructured":"Steinhoff G, Nesteruk J, Wolfien M, Kundt G, B\u00f6rgermann J, David R, et al. Cardiac function improvement and bone marrow response -: outcome analysis of the randomized PERFECT phase III clinical trial of intramyocardial CD133(+) application after myocardial infarction. EBioMedicine. 2017;22:208\u201324.","journal-title":"EBioMedicine"},{"issue":"4","key":"741_CR182","doi-asserted-by":"publisher","first-page":"236","DOI":"10.4252\/wjsc.v13.i4.236","volume":"13","author":"M Rheault-Henry","year":"2021","unstructured":"Rheault-Henry M, White I, Grover D, Atoui R. Stem cell therapy for heart failure: medical breakthrough, or dead end? World J Stem Cells. 2021;13(4):236\u201359.","journal-title":"World J Stem Cells."},{"issue":"2","key":"741_CR183","doi-asserted-by":"publisher","first-page":"186","DOI":"10.5966\/sctm.2015-0101","volume":"5","author":"S Golpanian","year":"2016","unstructured":"Golpanian S, Schulman IH, Ebert RF, Heldman AW, DiFede DL, Yang PC, et al. Concise review: review and perspective of cell dosage and routes of administration from preclinical and clinical studies of stem cell therapy for heart disease. Stem Cells Transl Med. 2016;5(2):186\u201391.","journal-title":"Stem Cells Transl Med"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-025-00741-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40256-025-00741-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-025-00741-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T00:59:57Z","timestamp":1757206797000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40256-025-00741-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":183,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["741"],"URL":"https:\/\/doi.org\/10.1007\/s40256-025-00741-0","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"type":"print","value":"1175-3277"},{"type":"electronic","value":"1179-187X"}],"subject":[],"published":{"date-parts":[[2025,6,27]]},"assertion":[{"value":"11 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No external funding was used in the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Quanchi Guo and Yang Hua declare that they have no potential conflicts of interest that might be relevant to the contents of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Writing: QG. Reviewing and revision: QG and YH.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors' contributions"}},{"value":"Data sharing is not applicable to this article as no datasets were generated for this review article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability statement"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}